ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0621

Predictive Parameters of Disease-related Damage Accrual in Patients with Systemic Lupus Erythematosus: A Machine Learning Analysis

Omer Pamuk1 and Hasan Cetin2, 1University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH, 2Cleveland Clinic Cole Eye Institute, Cleveland, OH

Meeting: ACR Convergence 2024

Keywords: Bioinformatics, Damage Index, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic systemic inflammatory disease that can affect multiple organs and systems. While there has been an improvement in lupus-related mortality in recent decades, disease-related chronic damage remains a significant issue. In this study, we aimed to evaluate predictive parameters for damage accrual in SLE by using machine learning analysis.

Methods: This retrospective study was conducted between 2014 and 2024. All patients met the modified ACR 1997 criteria for SLE. Clinical and laboratory data were obtained from their EMR records. The presence of a parameter was recorded if the patient ever had this symptom or finding. High disease activity was defined as a SLEDAI score >12 at any time during the follow-up period. Damage was evaluated using the SLICC damage index (SDI) at the time of the patients’ last clinical visit.

Our machine learning pipeline was both comprehensive and robust. Initially, we divided the dataset, setting aside 20% as the test set to ensure an unbiased evaluation of our model’s performance. From the remaining 80%, we further isolated 20% as a validation set to fine-tune our model. The training process leveraged the remaining 64% of the data.

We started with 54 potential predictive parameters. To enhance the model’s learning process and prevent overfitting, we eliminated parameters with higher than 90% correlation with the outcome and those with low internal variability less than 10%. And removed outliers with isolation forest method. We trained a random forest classifier model with 5-fold cross validation strategy. After the initial training, we optimized the model performance by fine-tuning using scikit-optimize library.

Results: A total of 403 SLE patients were included in this study (F/M: 359/44, mean age: 37.5 ± 13 years, disease duration: 83.2 ± 73.3 months). The most frequent manifestations of SLE in this study were arthritis, oral ulcers, and nephritis. Demographic and clinical features of the patients are shown in Table 1.

At the time of the last visit, 187 out of 403 patients (46.4%) had an SDI ≥ 1. To detect the predictive effect of selected parameters, we performed a permutation feature importance analysis. Our analysis showed that having ever experienced very severe active lupus, nephrotic range proteinuria, disease duration, lymphopenia, and low C4 had the strongest positive associations with SLE-related damage (Figure 2).

To determine the success of the system, we created a confusion matrix. The matrix showed that our analysis correctly classified 85 patients (70.2%). Conversely, the analysis misclassified 36 patients (29.8%).

Conclusion: Our ML analysis demonstrated that a computational method can be developed to predict chronic disease-related damage in patients with SLE. Our model identified that having ever experienced highly active SLE, nephrotic range proteinuria, disease duration, and lymphopenia are the strongest predictive parameters for SLE-associated damage. Further studies are needed to refine and validate this method. This model has the potential to be used in clinical practice to select and modify treatment plans for SLE patients.

Supporting image 1

Table 1. The comparison of SLE patients with and without disease-related damage.

Supporting image 2

Figure 1. ROC curve

Supporting image 3

Figure 2A. Feature Importance Plot
Figure 2B. Confusion Matrix


Disclosures: O. Pamuk: None; H. Cetin: None.

To cite this abstract in AMA style:

Pamuk O, Cetin H. Predictive Parameters of Disease-related Damage Accrual in Patients with Systemic Lupus Erythematosus: A Machine Learning Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/predictive-parameters-of-disease-related-damage-accrual-in-patients-with-systemic-lupus-erythematosus-a-machine-learning-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-parameters-of-disease-related-damage-accrual-in-patients-with-systemic-lupus-erythematosus-a-machine-learning-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology